user

Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma

被引：2
|
作者：
Wada-Shimosato, Yuko [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shin-ichi [1 ]
Sasaki, Koji [1 ]
Yanagimachi, Masakatsu [1 ]
Kajiwara, Ryosuke [1 ]
Shiba, Norio [1 ]
Murata, Hidetoshi [2 ]
Kawahara, Nobutaka [2 ]
Yamanaka, Shoji [3 ]
Tanoshima, Reo [1 ]
Ito, Shuichi [1 ]
机构：
[1] Yokohama City Univ, Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2019年 / 41卷 / 07期
基金：
日本学术振兴会;
关键词：
primary central nervous system lymphoma; intraventricular rituximab; non-Hodgkin lymphoma; CD20; MANAGEMENT; RADIATION; CHILDREN; THERAPY; TRIAL; BRAIN;
D O I：
10.1097/MPH.0000000000001291
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive type of extranodal non-Hodgkin lymphoma that carries an unsatisfactory prognosis. Treating refractory PCNSL is challenging because of resistance to conventional cytotoxic and intrathecal chemotherapies. Therefore, novel therapeutic approaches are needed. Here, we report a 12-year-old boy with CD20-positive PCNSL, which was refractory to combination chemotherapy and intravenous rituximab. However, the patient achieved complete remission after repeated intraventricular rituximab administration. The results of this case indicate that intraventricular rituximab is an effective option to treat refractory PCNSL in children.
引用
收藏
页码：571 / 573
页数：3
相关论文
共 50 条
  • [31] A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma
    Munoz, Javier
    Jaglowski, Samantha
    McKinney, Matthew S.
    Isufi, Iris
    Stiff, Patrick J.
    Sachs, Jessica
    Ranger, Ann
    Harris, Patricia
    Payumo, Francis
    Akard, Luke P.
    [J]. BLOOD, 2019, 134
  • [32] MAINTENANCE THERAPY USING RITUXIMAB FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Ichikawa, T.
    Kambara, H.
    Kosaka, H.
    Inoue, S.
    Yoshida, K.
    Onishi, M.
    Date, I.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1085 - 1085
  • [33] MAINTENANCE THERAPY USING RITUXIMAB FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Ichikawa, Tomotsugu
    Kurozumi, Kazuhiko
    Date, Isao
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 970 - 970
  • [34] Rituximab conjugated iron oxide nanoparticles for targeted imaging and enhanced treatment against CD20-positive lymphoma
    Song, Lina
    Chen, Yi
    Ding, Jiali
    Wu, Haoan
    Zhang, Wei
    Ma, Ming
    Zang, Fengchao
    Wang, Zhongqiu
    Gu, Ning
    Zhang, Yu
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (05) : 895 - 907
  • [35] Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
    Batara, Julette Marie F.
    Apor, Almira Doreen Abigail O.
    Mojica, Christianne, V
    Mondia, Mark Willy L.
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [36] Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
    Apor, Almira Doreen Abigail
    Batara, Julette
    Mojica, Christianne
    Mondia, Mark Willy
    [J]. NEUROLOGY, 2023, 100 (17)
  • [37] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [38] Efficacy and tolerability of rituximab-based chemotherapy in CD20-positive non-Hodgkin lymphoma (NHL)
    Polakiewicz-Gilowska, A.
    Cedrych, I.
    Nowara, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Primary central nervous system lymphoma revealed by multiple intraventricular mass lesions
    Marie Philippart
    Nicolas Mulquin
    Thierry Gustin
    Caroline Fervaille
    Frédéric London
    [J]. Acta Neurologica Belgica, 2019, 119 : 119 - 121
  • [40] Primary central nervous system lymphoma revealed by multiple intraventricular mass lesions
    Philippart, Marie
    Mulquin, Nicolas
    Gustin, Thierry
    Fervaille, Caroline
    London, Frederic
    [J]. ACTA NEUROLOGICA BELGICA, 2019, 119 (01) : 119 - 121
12345